National Society of Pediatric Hematologists and Oncologists: Clinical Guidelines

15 guidelines in the development of which the National Society of Pediatric Hematologists and Oncologists participated.

• Aggressive non-follicular lymphomas — diffuse large B-cell lymphoma, high-grade B-cell lymphoma with c-MYC and BCL2/BCL6 rearrangements, primary mediastinal B-cell lymphoma, gray zone lymphoma, Burkitt lymphoma, plasmablastic lymphoma.
  C83.3, C83.7, C83.8, C83.9, C85.2, C85.7…adults, children2024full text
• Anemia in chronic kidney disease
  D63.8adults, children2024full text
• Infantile hemangioma
  D18.0children2023full text
• Hemophilia
  D66, D67adults, children2023full text
• Other sphingolipidoses (Gaucher disease)
  E75.2children2024full text
• Iron deficiency anemia
  D50, D50.0, D50.1, D50.8, D50.9, D53.8…adults, children2024full text
• Immune thrombocytopenia
  D69.3children2024full text
• Hodgkin lymphoma
  C81adults, children2025full text
• Neuroblastoma
  C38.2, C47.0, C47.3, C47.4, C47.5, C47.6…children2025full text
• Nodal T-cell lymphomas
  C84.5, C84.6, C84.7, C84.9, C86.0, C86.1…adults, children2025full text
• Paroxysmal Nocturnal Hemoglobinuria
  D59.5adults, children2024full text
• Acquired pure red cell aplasia (erythroblastopenia)
  D60.0, D60.1, D60.8, D60.9adults, children2024full text
• Rare coagulopathies: hereditary deficiency of blood coagulation factors II, VII, X
  D68.2adults, children2023full text
• Follicular lymphoma
  C82, C85.9adults, children2024full text
• Chronic myeloid leukemia
  C92.1adults, children2024full text